Programmatic implications of acute and early HIV infection

Journal of Infectious Diseases

Volumn 212, Issue 9, 2015, Pages 1351-1360

  Suthar, Amitabh B ^a   Granich, Reuben M ^b   Kato, Masaya ^c   Nsanzimana, Sabin ^d   Montaner, Julio S G ^e   Williams, Brian G ^f  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b INTERNATIONAL ASSOCIATION OF PROVIDERS OF AIDS CARE   (United States)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d RWANDA BIOMEDICAL CENTER   (Rwanda)

^e BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^f UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

acute HIV infection; blood safety; early HIV infection; HIV incidence; HIV testing; national strategic plan; recent HIV infection

Indexed keywords

ANTIGEN P24; ANTIRETROVIRUS AGENT; BIOLOGICAL MARKER; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS DNA; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ANTIBODY DETECTION; ANTIVIRAL THERAPY; BLOOD ANALYSIS; BLOOD SAFETY; CHEMOPROPHYLAXIS; COHORT ANALYSIS; CONDOM USE; DISEASE DURATION; DISEASE SURVEILLANCE; EARLY HUMAN IMMUNODEFICIENCY VIRUS INFECTION; EPIDEMIC; HEALTH CARE ACCESS; HEALTH CARE PLANNING; HEALTH INSURANCE; HIV RAPID TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION CONTROL; INFECTION RISK; MATHEMATICAL MODEL; META ANALYSIS (TOPIC); NONHUMAN; OPIATE SUBSTITUTION TREATMENT; PHYLOGENY; PREVALENCE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEXUAL BEHAVIOR; SYSTEMATIC REVIEW (TOPIC); VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION; VIRUS TRANSMISSION; ACUTE DISEASE; BLOOD; HIV INFECTIONS; THEORETICAL MODEL; TRANSMISSION;

ACUTE DISEASE; BIOMARKERS; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; INCIDENCE; MODELS, THEORETICAL; PREVALENCE; RISK FACTORS; VIRAL LOAD;

EID: 84946140306     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv430     Document Type: Review

References (81)

1. Fiebig EW, Wright DJ, Rawal BD, et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003; 17: 1871-9
2. Robb ML. Viral dynamics and immune response in acute infection and their impact on viral set-point. In: AIDS Vaccine 2012 Conference. Boston, United States of America, 11 September 2012
3. Joint United Nations Programme on HIV/AIDS, World Health Organization. When and how to use assays for recent infection to estimate HIV incidence at a population level, 2011. http://www.who.int/entity/diagnostics
4. World Health Organization. Technical update on HIV incidence assays for surveillance and monitoring purposes, 2015. http://www.unaids.org/sites/default/files/media-asset/HIVincidenceassayssurveillancemonitoring-en. pdf. Accessed 11 April 2015
5. Morgan D, Mahe C, Mayanja B, Okongo JM, Lubega R, Whitworth JA. HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries?. AIDS 2002; 16: 597-603
6. Nsanzimana S, Remera E, Kanters S, et al. Life expectancy among HIVpositive patients in Rwanda: a retrospective observational cohort study. Lancet Glob Health 2015; 3: e169-77
7. Mocroft AJ, Lundgren JD, d Armino Monforte A, et al. Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study Group. Int J Epidemiol 1997; 26: 400-7
8. Cohen MS, Shaw GM, McMichael AJ, Haynes BF. Acute HIV-1 infection. N Engl J Med 2011; 364: 1943-54
9. Cohen MS, Dye C, Fraser C, Miller WC, Powers KA, Williams BG. HIV treatment as prevention: debate and commentary-will early infection compromise treatment-as-prevention strategies?. PLoS Med 2012; 9: e1001232
10. Phanuphak P, Lo YR. Implementing early diagnosis and treatment: programmatic considerations. Curr Opin HIV AIDS 2015; 10: 69-75
11. Pilcher CD, Tien HC, Eron JJ Jr, et al. Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis 2004; 189: 1785-92
12. Busch MP, Lee LL, Satten GA, et al. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Transfusion 1995; 35: 91-7
13. World Health Organization. Screening Donated Blood for Transfusion-Transmissible Infections, 2010. http://www.who.int/bloodsafety/ScreeningDonatedBloodforTransfusion.pdf. Accessed 18 July 2014
14. World Health Organization. HIV assays: laboratory performance and other operational characteristics of rapid diagnostic tests, 2015. http://www.who.int/entity/diagnostics
15. Shanks L, Klarkowski D, O Brien DP. False positive HIV diagnoses in resource limited settings: operational lessons learned for HIV programmes. PLoS One 2013; 8: e59906
16. Sands A, Beelaert G, Fransen K, Vercauteren G. Poor antigen sensitivity of three innovative rapid diagnostic tests (RDTs) for detection of HIV-1 p24 antigen and HIV-1/2 antibodies. In: XIX International AIDS Conference, Washington, D. C., 2012
17. World Health Organization. Database on procurement of HIV and hepatitis products, 2015. http://www.who.int/entity/hiv/pub/amds/amds-database-dec2014.xlsx. Accessed 3 July 2015
18. Boily MC, Baggaley RF, Wang L, et al. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 2009; 9: 118-29
19. Powers KA, Poole C, Pettifor AE, Cohen MS. Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis. Lancet Infect Dis 2008; 8: 553-63
20. World Health Organization. Consolidated guidelines on HIV testing services, 2015. http://apps.who.int/iris/bitstream/10665/179870/1/9789241508926-eng.pdf. Accessed 14 July 2015
21. South African National AIDS Council. HIV Counselling and Testing (HCT) Policy Guidelines, 2010. http://www.sanac.org.za/resources/doc-download/2-department-of-health-hct-policy-guidelines. Accessed 30 April 2014
22. Guy R, Gold J, Calleja JM, et al. Accuracy of serological assays for detection of recent infection with HIV and estimation of population incidence: a systematic review. Lancet Infect Dis 2009; 9: 747-59
23. Kassanjee R, Pilcher CD, Keating SM, et al. Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository. AIDS 2014; 28: 2439-49
24. Barnighausen T, McWalter TA, Rosner Z, Newell ML, Welte A. HIV incidence estimation using the BED capture enzyme immunoassay: systematic review and sensitivity analysis. Epidemiology 2010; 21: 685-97
25. Wang R, Lagakos SW. On the use of adjusted cross-sectional estimators of HIV incidence. J Acquir Immune Defic Syndr 2009; 52: 538-47
26. Kaufmann GR, Cunningham P, Kelleher AD, et al. Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection. The Sydney Primary HIV Infection Study Group. J Infect Dis 1998; 178: 1812-5
27. Novitsky V, Woldegabriel E, Kebaabetswe L, et al. Viral load and CD4+T-cell dynamics in primary HIV-1 subtype C infection. J Acquir Immune Defic Syndr 2009; 50: 65-76
28. Pilcher CD, Joaki G, Hoffman IF, et al. Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection. AIDS 2007; 21: 1723-30
29. Schacker TW, Hughes JP, Shea T, Coombs RW, Corey L. Biological and virologic characteristics of primary HIV infection. Ann Intern Med 1998; 128: 613-20
30. Little SJ, McLean AR, Spina CA, Richman DD, Havlir DV. Viral dynamics of acute HIV-1 infection. J Exp Med 1999; 190: 841-50
31. Attia S, Egger M, Muller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 2009; 23: 1397-404
32. Loutfy MR, Wu W, Letchumanan M, et al. Systematic review of HIV transmission between heterosexual serodiscordant couples where the HIV-positive partner is fully suppressed on antiretroviral therapy. PLoS One 2013; 8: e55747
33. Rodger A, Bruun T, Cambiano V, et al. HIV transmission risk through condomless sex if HIV+ partner on suppressive ART: PARTNER study. In: Conference on Retroviruses and Opportunistic Infections, Boston, Massachusetts, 2014
34. Wood E, Kerr T, Marshall BD, et al. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ 2009; 338: b1649
35. Blaser N, Wettstein C, Estill J, et al. Impact of viral load and the duration of primary infection on HIV transmission: systematic review and metaanalysis. AIDS 2014; 28: 1021-9
36. Williams B, Lima V, Gouws E. Modelling the Impact of Antiretroviral Therapy on the Epidemic of HIV. Curr HIV Res 2011; 9: 367-82
37. Williams BG, Granich R, Dye C. Role of acute infection in HIV transmission. Lancet 2011; 378: 1913; author reply 4-5
38. Weller S, Davis K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev 2002: CD003255
39. Okwundu CI, Uthman OA, Okoromah CA. Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals. Cochrane Database Syst Rev 2012; 7: CD007189
40. MacArthur GJ, van Velzen E, Palmateer N, et al. Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness. Int J Drug Policy 2014; 25: 34-52
41. Joint United Nations Programme on HIV and AIDS. MDG6: 15 years, 15 lessons of hope from the AIDS response, 2015. http://www.unaids. org/sites/default/files/media-asset/MDG6Report-en.pdf. Accessed 24 July 2015
42. Wellings K, Collumbien M, Slaymaker E, et al. Sexual behaviour in context: a global perspective. Lancet 2006; 368: 1706-28
43. Epstein H, Morris M. Concurrent partnerships and HIV: an inconvenient truth. J Int AIDS Soc 2011; 14: 13
44. Eaton JW, Hallett TB, Garnett GP. Concurrent sexual partnerships and primary HIV infection: a critical interaction. AIDS Behav 2011; 15: 687-92
45. Sawers L, Stillwaggon E. Concurrent sexual partnerships do not explain the HIV epidemics in Africa: a systematic review of the evidence. J Int AIDS Soc 2010; 13: 34
46. Ma ZM, Stone M, Piatak M Jr, et al. High specific infectivity of plasma virus from the pre-ramp-up and ramp-up stages of acute simian immunodeficiency virus infection. J Virol 2009; 83: 3288-97
47. Keele BF, Giorgi EE, Salazar-Gonzalez JF, et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci USA 2008; 105: 7552-7
48. Fraser C, Lythgoe K, Leventhal GE, et al. Virulence and pathogenesis of HIV-1 infection: an evolutionary perspective. Science 2014; 343: 1243727
49. Miller WC, Rosenberg NE, Rutstein SE, Powers KA. Role of acute and early HIV infection in the sexual transmission of HIV. Curr Opin HIV AIDS 2010; 5: 277-82
50. Abu-Raddad LJ, Longini IM Jr. No HIV stage is dominant in driving the HIV epidemic in sub-Saharan Africa. AIDS 2008; 22: 1055-61
51. Hayes RJ, White RG. Amplified HIV transmission during early-stage infection. J Infect Dis 2006; 193: 604-5; author reply 5-6
52. Hollingsworth TD, Anderson RM, Fraser C. HIV-1 transmission, by stage of infection. J Infect Dis 2008; 198: 687-93
53. Pinkerton SD. Probability of HIV transmission during acute infection in Rakai, Uganda. AIDS Behav 2008; 12: 677-84
54. Powers KA, Ghani AC, Miller WC, et al. The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study. Lancet 2011; 378: 256-68
55. Salomon JA, Hogan DR. Evaluating the impact of antiretroviral therapy on HIV transmission. AIDS 2008; 22(suppl 1): S149-59
56. Goodreau SM, Cassels S, Kasprzyk D, Montano DE, Greek A, Morris M. Concurrent partnerships, acute infection and HIV epidemic dynamics among young adults in Zimbabwe. AIDS Behav 2012; 16: 312-22
57. Wawer MJ, Gray RH, Sewankambo NK, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005; 191: 1403-9
58. Fonner VA, Denison J, Kennedy CE, O Reilly K, Sweat M. Voluntary counseling and testing (VCT) for changing HIV-related risk behavior in developing countries. Cochrane Database Syst Rev 2012; 9: CD001224
59. Bellan SE, Dushoff J, Galvani AP, Meyers LA. Reassessment of HIV-1 acute phase infectivity: accounting for heterogeneity and study design with simulated cohorts. PLoS Med 2015; 12: e1001801
60. Pinkerton SD. How many sexually-acquired HIV infections in the USA are due to acute-phase HIV transmission?. AIDS 2007; 21: 1625-9
61. Xiridou M, Geskus R, De Wit J, Coutinho R, Kretzschmar M. Primary HIV infection as source of HIV transmission within steady and casual partnerships among homosexual men. AIDS 2004; 18: 1311-20
62. Coutinho FA, Lopez LF, Burattini MN, Massad E. Modelling the natural history of HIV infection in individuals and its epidemiological implications. Bull Math Biol 2001; 63: 1041-62
63. Kretzschmar M, Dietz K. The effect of pair formation and variable infectivity on the spread of an infection without recovery. Math Biosci 1998; 148: 83-113
64. Koopman JS, Jacquez JA, Welch GW, et al. The role of early HIV infection in the spread of HIV through populations. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14: 249-58
65. Pinkerton SD, Abramson PR. Implications of increased infectivity in early-stage HIV infection. Application of a Bernoulli-process model of HIV transmission. Eval Rev 1996; 20: 516-40
66. Jacquez JA, Koopman JS, Simon CP, Longini IM Jr. Role of the primary infection in epidemics of HIV infection in gay cohorts. J Acquir Immune Defic Syndr 1994; 7: 1169-84
67. Prabhu VS, Hutchinson AB, Farnham PG, Sansom SL. Sexually acquired HIV infections in the United States due to acute-phase HIV transmission: an update. AIDS 2009; 23: 1792-4
68. Volz EM, Ionides E, Romero-Severson EO, Brandt MG, Mokotoff E, Koopman JS. HIV-1 Transmission during Early Infection in Men Who Have Sex with Men: A Phylodynamic Analysis. PLoS Med 2013; 10: e1001568
69. Brown AE, Gifford RJ, Clewley JP, et al. Phylogenetic reconstruction of transmission events from individuals with acute HIV infection: toward more-rigorous epidemiological definitions. J Infect Dis 2009; 199: 427-31
70. Brenner BG, Roger M, Routy JP, et al. High rates of forward transmission events after acute/early HIV-1 infection. J Infect Dis 2007; 195: 951-9
71. Lewis F, Hughes GJ, Rambaut A, Pozniak A, Leigh Brown AJ. Episodic sexual transmission of HIV revealed by molecular phylodynamics. PLoS Med 2008; 5: e50
72. Yerly S, Vora S, Rizzardi P, et al. Acute HIV infection: impact on the spread of HIV and transmission of drug resistance. AIDS 2001; 15: 2287-92
73. Pao D, Fisher M, Hue S, et al. Transmission of HIV-1 during primary infection: relationship to sexual risk and sexually transmitted infections. AIDS 2005; 19: 85-90
74. Dennis AM, Herbeck JT, Brown AL, et al. Phylogenetic studies of transmission dynamics in generalized HIV epidemics: an essential tool where the burden is greatest?. J Acquir Immune Defic Syndr 2014; 67: 181-95
75. May RM, Anderson RM. Transmission dynamics of HIV infection. Nature 1987; 326: 137-42
76. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 2009; 373: 48-57
77. Kato M, Granich R, Duc Bui D, et al. The potential impact of expanding antiretroviral therapy and combination prevention in Vietnam: towards elimination of HIV transmission. J Acquir Immune Defic Syndr 2013; 63: 142-9
78. Shannon K, Strathdee SA, Goldenberg SM, et al. Global epidemiology of HIV among female sex workers: influence of structural determinants. Lancet 2015; 385: 55-71
79. Tanser F, Barnighausen T, Grapsa E, Zaidi J, Newell ML. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science 2013; 339: 966-71
80. Tanser F, De Oliveira T, Maheu-Giroux M, Barnighausen T. Concentrated HIV subepidemics in generalized epidemic settings. Curr Opin HIV AIDS 2014; 9: 115-25
81. Eaton JW, Hallett TB. Why the proportion of transmission during early-stage HIV infection does not predict the long-term impact of treatment on HIV incidence. Proc Natl Acad Sci USA 2014; 111: 16202-7